Study visits and follow‐up
ADVERSE EVENTS, SECONDARY
All subjects will be followed up at 1 month (±7 days), 6 months (±7 days), and 12 months (±7 days) in the outpatient clinic, and at 2 weeks (±7 days), 2 months (±7 days), and 3 months (±7 days) by telephone. The patients' primary and secondary endpoints, (severe) adverse events, medications, and the results of the tests mentioned above will be carefully recorded during the follow‐up.